Hokama Ryo, Goto Norihiro, Shinzato Moriaki, Tsuchiya Hiroyuki, Hoshino Kota
Emergency and Critical Care Center, Okinawa Prefectural Nanbu Medical Center and Children's Medical Center, Haebaru, JPN.
Cureus. 2025 Aug 5;17(8):e89451. doi: 10.7759/cureus.89451. eCollection 2025 Aug.
The indications for extracorporeal membrane oxygenation (ECMO) have broadened in clinical practice, and its use in circulatory failure caused by acute drug intoxication has become more frequent. We reviewed three cases of venoarterial (VA) ECMO use for intoxication at our hospital. Three cases (aged 60-69 years) developed refractory shock following intentional overdose, including calcium channel blockers. Despite maximal pharmacologic support, all exhibited progressive hemodynamic deterioration and elevated serum lactate levels (max 8.0-20.0 mmol/L). VA ECMO was initiated on the day of admission in each case. Hemodynamic stability was restored, and ECMO was discontinued within 4 to 6 days. All patients survived hospital discharge without major ECMO-related complications. These cases highlight the potential benefit of the timely initiation of VA ECMO in selected intoxicated patients with drug-induced cardiogenic shock. Comparison with other clinical experiences suggests better outcomes when ECMO is implemented before cardiac arrest. Lactate levels at the time of ECMO initiation may serve as a prognostic indicator. The timely initiation of VA ECMO may be life-saving in patients with acute drug intoxication and refractory cardiogenic shock. Careful patient selection, guided by toxin type and pre-ECMO lactate trends, is essential to optimize outcomes.
体外膜肺氧合(ECMO)在临床实践中的应用指征已有所拓宽,其在急性药物中毒所致循环衰竭中的应用也日益频繁。我们回顾了我院3例因中毒而使用静脉-动脉(VA)ECMO的病例。3例患者(年龄60 - 69岁)在故意过量服药(包括钙通道阻滞剂)后出现难治性休克。尽管给予了最大程度的药物支持,但所有患者均出现了进行性血流动力学恶化和血清乳酸水平升高(最高达8.0 - 20.0 mmol/L)。3例患者均在入院当天开始使用VA ECMO。血流动力学恢复稳定,ECMO在4至6天内停用。所有患者均存活出院,无重大ECMO相关并发症。这些病例凸显了在选定的药物性心源性休克中毒患者中及时启动VA ECMO的潜在益处。与其他临床经验相比,提示在心脏骤停前实施ECMO可获得更好的结局。启动ECMO时的乳酸水平可作为一项预后指标。对于急性药物中毒和难治性心源性休克患者,及时启动VA ECMO可能挽救生命。根据毒素类型和ECMO前乳酸变化趋势进行仔细的患者选择,对于优化结局至关重要。